Stay updated on Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page’s revision/version indicator at the bottom was updated from v3.5.2 to v3.5.3, reflecting an incremental update to the site itself rather than the underlying clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-25T18:44:09.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No visible changes to study details or page layout are indicated.
    Difference
    0.1%
    Check dated 2026-04-18T13:35:28.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Revision: v3.5.0 replaced v3.4.3 in the page header/footer. No observed changes to the study details, eligibility criteria, or navigation.
    Difference
    0.1%
    Check dated 2026-03-21T00:52:26.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T18:02:13.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2, replacing Revision: v3.4.1. This is a minor UI/content label update that does not affect study information or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:31:52.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; no study content or location details appear to be affected, and the page's core purpose remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:14:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page.